2021年3期
亚洲社会药学杂志
- EU Real-World Evidence Supports New Drug Research and Development Decisions and Its Implications for China
- Real-World Evidence Supporting New Drug Review and Approval in European Union and Its Enlightenment to China
- The Enlightenment of EU Real-World Evidence Supporting the Inclusion of Rare Disease Drugs in Medical Insurance Decisions to China
- EU Real-World Evidence Supports the Expansion Indications for Drugs and Its Enlightenment to China
- Research on Real-World Evidence and Application in EU and Its Enlightment to China
- The Enlightenment of FDA’s “Real-World Evidence Program Framework” to China
- Application of Real-World Evidence in Regulatory Decision-Making for Medical Devices
- How Real-World Evidence Supports Healthcare Decisions in EU and Its Enlightment to China
- Research on the Pragmatic Clinical Trial Design Based on Real-World Study
- Research on Retrospective Studies of Real-World Study and Its Selection Bias
- Discussion on the Application of Real-World Study in the Inheritance and Development of Empirical Prescriptions of Traditional Chinese Medicine
- Analysis of Drug Use in Outpatients with Hypertension Based on Real-World Study
- Research Hotspots and Trends Analysis of Real-World Data Based on Social Network Analysis and Knowledge Graph